BioAro

BioAro provides advanced precision health diagnostics using multiomic technologies including genomics, epigenetics, proteomics, metabolomics and microbiome analyses. Their commercial offerings include high-resolution genome/exome sequencing with AI-powered interpretation tools. They operate clinics focused on longevity/healthspan as well as providing R&D services for new drug/treatment discovery. The company leverages proprietary platforms such as PanOmiQ for comprehensive omic profiling and integrates digital tools like the BioEMR system for patient data management. They emphasize secure data handling via blockchain technology. No clinical trial results are reported since their primary business model centers on diagnostics/services rather than therapeutic development.